English
This article is from Journal of Research in Medical Sciences : The Official Journal of Isfahan University of Medical Sciences , volume 17 . Abstract Background:: Hyperuricemia has been associated with the development of high blood pressure (BP). We studied the effects of allopurinol therapy in hyperuricemic hemodialysis (HD) patients with high BP. Materials and Methods:: This single-blind, randomized cross-over clinical study involved 55 HD patients with serum uric acid level > 6.5 (men) and > 5.5 mg/dL (women). They were randomly divided in two groups, each of which went through two phases. Group-1 in phase-1 received 100 mg/day orally of allopurinol for three months; while Group-2 was given whatever medication they received prior to the study. After two months of washing period, the groups were crossed-over. The BP levels were measured before and after HD during the eight months study period. Results:: Fifty-three patients completed the study (33 men and 20 women, with mean age of 55.8 years). Uric acid levels decreased significantly during the12 weeks of allopurinol therapy (7.71 ± 1.53 to 5.2 ± 1.2 P < 0.005). Overall, after the 12 weeks of allopurinol therapy, systolic and dia
Sign in with your free account to read, download EPUBs or listen.
Ebook · The effect of allopurinol on lowering blood pressure in hemodialysis patients with hyperuricemia. · Jalalzadeh, Mojgan, Nurcheshmeh, Zeinalabedin, Mohammadi, Ramin, Mousavinasab, Nouraddin, Ghadiani, Mohammad Hassan · Internet Archive